{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-017489","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2022-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.439350+00:00","generated_at":"2026-06-25T00:19:12.919601+00:00","sec_items":["5.07","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"ChromaDex holds 2022 annual meeting; re-elects seven directors, appoints Steven Rubin as Lead Independent Director","bullets":["All seven director nominees elected at June 16 annual meeting; votes ranged from ~28.3M to ~37.3M for.","Shareholders ratified Marcum LLP as auditor for FY2022 with 47.7M for, 1.8M against.","Advisory say-on-pay proposal passed with 36.0M for, 1.1M against.","Board appointed Steven Rubin as Lead Independent Director following Kurt Gustafson's departure.","Board committee assignments reconstituted; Rubin chairs Audit, Patrick chairs Compensation, Cohen chairs Nominating."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-017489","json":"https://secwatch.observer/filing/0001628280-22-017489.json","markdown":"https://secwatch.observer/filing/0001628280-22-017489.md","text":"https://secwatch.observer/filing/0001628280-22-017489.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022017489/0001628280-22-017489-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022017489/cdxc-20220616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:19:12.919601+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}